10 Stocks on Jim Cramer’s Radar

In this piece, we will look at the stocks Jim Cramer recently discussed.

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed the latest figures for GDP growth. The Commerce Department’s GDP data for the third quarter showed that the economy grew by 4.3% in the September quarter. The growth figure sharply exceeded economists’ expectations of a 3.2% growth. A key factor in the data was consumer spending which which grew at 3.5% which was the fastest pace in the year. Crucially, in his morning appearance on December 19th, the CNBC TV host had countered a pessimistic report by Bank of America by remarking that he believed consumer spending would be “much stronger.” As the data hit the wires, Cramer commented:

“Right, now we’ve got a couple of things going. First of all, it’s backward, it’s not forward. Second, I think that there are people who recognize that we have a bifurcated economy. The rich people are spending like crazy, the people who are less well off, are holding back. So the GDP may not be necessarily be an indicator of the, of the health of the country as much as I typically think it is.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down the stocks he mentioned during CNBC’s Squawk on the Street aired on December 23rd. We also provided hedge fund sentiment for each stock as of the third quarter of 2025, which was taken from Insider Monkey’s database of 978 hedge funds.

​Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

10. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holdings: 50

Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and Drug Administration’s (FDA) approval for its weight loss pill. The approval made the Wegovy pill the first of its kind, and it led to the firm’s shares closing 7.30% higher. The approval marked a key win for Novo Nordisk A/S (NYSE:NVO) as the firm has reportedly struggled against Eli Lilly in the weight loss drug market. Following the Wegovy pill approval, the pharmaceutical company moved fast, as a report from the Chinese outlet Yicai suggested that Novo Nordisk A/S (NYSE:NVO) had cut the prices of its highest dosage Wegovy drugs in half in some Chinese provinces. After the approval, BMO Capital reiterated a Market Perform rating and a $46 share price target for the company. The financial firm outlined that Novo Nordisk A/S (NYSE:NVO) could benefit from a first-mover advantage in the oral weight loss drug market and added that it could face competitive challenges in the future. Cramer shared his own unique take on the matter, as he commented that Novo Nordisk A/S (NYSE:NVO) might see resistance from physicians when it comes to taking away market share from Eli Lilly:

“Now, remember, that a pill is much preferred in the country, versus the shot. If you are taking Wegovy, then people will move over, quickly migrate over to Wegovy pill. . .let’s say you are taking Mounjaro right now, Eli Lilly, they are reluctant to say listen you should go do Wegovy. Because what they’ll say is listen, you tolerate Mounjaro, and we just care about toleration. And that’s been the way things go. And I think people who think, wow, there are people who are going to be really excited to move over to the pill. Their advice from the doctors is going to be, no, there could be different reactions. And apparently the doses are so high, that there are some different changes in diet that you might have to do. We don’t know enough about what the side effects are, we know this. The profession just doesn’t like you to switch from one drug to another.

“I think that there are a lot of people who are scared to give themselves a shot. A lot of people who think the shot hurts. You have to take the shot every once a week. So I think, yeah it’s a big win, I didn’t see it, my charitable trust owns Eli Lilly, and I think three months from now we say, okay, Lilly’s in the market but, last night I’m doing Mad Money and I’m saying, oh jeez, this isn’t supposed to happen. Because I didn’t want to see, I knew that for our trust that Eli Lilly would be down, I don’t think it should be down . . .

“Anytime you have to put something in cold, although once you take it out,a  lot of these drugs, once you take it out, you’re okay, but you gotta keep it refrigerated. People don’t like that. People really have a shorter term. . .people stop after 13 months, on the shot, they just don’t like it. And this is going to be much longer. That’s something David Ricks has talked about, the CEO of Lilly. He’s told me, when he’s come on Mad Money, don’t forget,  the people just, they stop taking it. And one of the reasons they stop taking it, is because, wow I don’t want to take a shot anymore. And they also say, listen I’m thin, so I’m fine. Completely untrue, these are lifetime drugs.”

9. ServiceNow, Inc. (NYSE:NOW)

Number of Hedge Fund Holdings: 104

Enterprise workflow management software services provider ServiceNow, Inc. (NYSE:NOW) announced an important deal the day this show was aired, as it announced that it would acquire cybersecurity firm Armis for a $7.5 billion price tag. Throughout 2025, Cramer has maintained that the cybersecurity sector continues to be attractive in the broader software industry as it benefits from national security tailwinds and the growth in data usage stemming from AI. Earlier in the month, Bernstein had maintained a $1,093 share price target for ServiceNow, Inc. (NYSE:NOW) and assigned an Overweight rating to the shares. As reports of the merger made rounds in markets ahead of the official announcement and led to weakness in the shares, the financial firm commented that channel checks indicated demand acceleration and the selloff hinted at undervaluation. After the deal was announced, Cramer was unsurprisingly optimistic, given his thoughts surrounding the cybersecurity sector:

“No, and this is very important, because, ServiceNow, is in many ways, very important within the organization. Whenever they get in, but they haven’t been strong in something that everybody wants, which is cybersecurity. And this is, I think, integral to the suite, to a platform that you have. ServiceNow going beyond, just a vertical of IT and going to a platform. That’s what everybody is doing. And I think it’ll be important, because the compression of the price-to-earnings multiple for ServiceNow is huge.”

8. Tyson Foods, Inc. (NYSE:TSN)

Number of Hedge Fund Holdings: 38

Tyson Foods Inc. (NYSE:TSN) is one of the largest packaged food companies in America. Its shares are flat year-to-date, with media reports pinning the blame on several factors. These include a demand by President Trump that the firm be investigated for price fixing and the firm paying $85 million in October to consumers after a lawsuit involving similar allegations. On a more positive note, S&P changed its outlook for Tyson Foods Inc. (NYSE:TSN) to Positive and Stable and affirmed a BBB credit rating.  The agency commented that the meat company had accelerated its debt reduction process and increased its profitability by benefiting from chicken. Chicken has become an important market in the US as beef prices touch record highs due to herd problems. Tyson Foods Inc. (NYSE:TSN)’s BBB rating and a Stable outlook were also reiterated by Fitch in December. Fitch remarked that the firm could face as much as $500 million of beef losses in its fiscal year 2026. Cramer discussed the impact of beef on Tyson Foods Inc. (NYSE:TSN) and discussed the initiatives the firm is taking to navigate through a tough market:

“We talked about the growth in economy, the GDP. But there is inflation, and one of the areas that has the worst inflation is beef. And that has to do with the way we get cattle, which it takes a long time. The herd is incredibly low, lowest in 50 years. And so today we have a small Nebraska town reeling from the exit of the meat packing giant, Tyson. They can’t make money, they can’t make money in this. And unless the President just says, listen, we’re going to waive all the tariffs, they’ve done some. Cattle just is going to stay high, it’s up 21% for the year, it’s up 7% for the month! So you’ve got the staple of America, beef, costing far more than it used to, and it’s rippling through. Tyson is doing everything it can this year to try to make it so that they make more money. Where they’re rationalizing the workforce. But a lot of people are going to get laid off. And I think I would keep in mind that I still think the admininstration has to recognize that when you go to the supermarket, there are parts of it that are just like a no fly zone. And the beef section, even in Costco, it’s just devastating. . .”

7. Texas Roadhouse, Inc. (NASDAQ:TXRH)

Number of Hedge Fund Holdings: 37

Casual dining restaurant firm Texas Roadhouse, Inc. (NASDAQ:TXRH) crossed Jim Cramer’s radar as the CNBC TV host discussed beef prices. Its shares are down by 7% year-to-date amidst broader struggles faced by the restaurant industry. Stifel maintained a Hold rating and a $188 share price target for the stock in December. The financial firm pointed out that while Texas Roadhouse, Inc. (NASDAQ:TXRH) was fighting historically high prices, the restaurant company was focused on a pricing strategy focused on providing customers with value. Stifel added that the pricing strategy, coupled with a customer value perception, could help the firm with same-store sales growth. Along with Stifel, Wells Fargo also shared its take on Texas Roadhouse, Inc. (NASDAQ:TXRH) in December. Bumping the rating to Overweight and setting a $195 share price target, the bank outlined that the share price at the time of coverage provided an attractive entry point. Like the analysts, Cramer’s previous comments about Texas Roadhouse, Inc. (NASDAQ:TXRH) have praised the firm’s pricing strategy. In this appearance, he discussed the firm in the context of the impact of beef prices on the restaurant industry:

“Oh it’s been terrible. And you take a look at some of the great restaurants. And here I’m speaking about Texas Roadhouse, which we own for the charitable trust. . .You, it’s every hard for them to make do in the sense of what they’re doing is they’re trying to do these very small price increases that are not covering the cost of the beef. So then they’re missing the quarter. But they don’t want to lose the traffic. And it accounts for a lot of the underperformance, of many of the restaurants. . .this is a tough story.”

6. Brinker International, Inc. (NYSE:EAT)

Number of Hedge Fund Holdings: 51

Brinker International, Inc. (NYSE:EAT) is a casual dining restaurant company. Like those of its peers in the restaurant industry, the firm’s shares have also struggled in 2025. Year-to-date, Brinker International, Inc. (NYSE:EAT)’s shares are up by 5%, with the bulk of these gains having come since early November, courtesy of a 41% rise. In mid-November, Mizuho kept an Outperform rating and a $155 share price target for Brinker International, Inc. (NYSE:EAT). The financial firm commented that the restaurant company could experience same-store sales growth for the year’s first 11 months despite the sector’s struggles. Mizuho added that Brinker International, Inc. (NYSE:EAT) could also experience cost benefits due to lower tariffs on Brazil. Cramer was cautious about the stock in November, as on the 10th, he advised viewers to buy a few shares and then wait and watch. This time, he discussed Brinker International, Inc. (NYSE:EAT) in the context of the broader restaurant industry:

“Oh it’s been terrible. And you take a look at some of the great restaurants. And here I’m speaking about Texas Roadhouse, which we own for the charitable trust. Brinker, which is such a well run company. It’s known for hamburgers. You, it’s every hard for them to make do in the sense of what they’re doing is they’re trying to do these very small price increases that are not covering the cost of the beef. So then they’re missing the quarter. But they don’t want to lose the traffic. And it accounts for a lot of the underperformance, of many of the restaurants. . .this is a tough story.”

5. Darden Restaurants, Inc. (NYSE:DRI)

Number of Hedge Fund Holdings: 31

Full-service restaurant firm Darden Restaurants, Inc. (NYSE:DRI)’s shares are flat year to date to make it another struggling restaurant stock in 2025. The stock experienced a notable 7.7% dip in September after the firm’s fiscal first-quarter earnings report. The results saw Darden Restaurants, Inc. (NYSE:DRI)’s $3.04 billion in revenue meet analyst estimates and its $1.97 in adjusted EPS miss $2 in estimates. During the earnings call, CEO Rick Cardenas commented that his company was experiencing a growth in visits from higher-income customers. Darden Restaurants, Inc. (NYSE:DRI)’s second fiscal quarter EPS of $2.08 also missed analyst estimates of $2.10. Following the second quarter earnings, Stephens cut the firm’s share price target to $205 from $215 and kept an Equal Weight rating on the stock. The financial firm explained that the restaurant company was experiencing softness in its well-known Olive Garden restaurants. Later, BTIG reiterated a Buy rating and a $225 share price target for Darden Restaurants, Inc. (NYSE:DRI). In his earlier comments about the firm, Cramer pointed out that the company was benefiting from chicken on its menu. He reiterated the thoughts this time around as well:

“. . .although Darden did okay, because they’re largely chicken. And chicken is in large supply.”

4. Chipotle Mexican Grill, Inc. (NYSE:CMG)

Number of Hedge Fund Holdings: 65

Chipotle Mexican Grill, Inc. (NYSE:CMG) was the final restaurant stock that Jim Cramer discussed in this show. The firm’s shares are among the worst performers in its group as they are down by 37.8% year-to-date. Two notable dips are behind the performance, with the latest coming in October when Chipotle Mexican Grill, Inc. (NYSE:CMG)’s stock tumbled by 18%. The dip occurred after the firm’s third-quarter earnings report, which saw it cut its full-year same-store sales guidance for the third consecutive quarter. Several analysts have discussed Chipotle Mexican Grill, Inc. (NYSE:CMG)’s stock in December. For instance, Evercore ISI reiterated an Outperform rating on the shares and a $45 share price target. The financial firm pointed out that Chipotle Mexican Grill, Inc. (NYSE:CMG)’s same-store sales trends had only grown modestly. It also increased the EPS estimate to $1.19 from $1.17. Goldman Sachs kept a Buy rating and a $45 share price target this month as it appreciated Chipotle Mexican Grill, Inc. (NYSE:CMG)’s upcoming High Protein Menu. Cramer remarked that while the firm’s CEO was doing everything right, the market was simply too tough:

“And they are, they’ve got a very lower price protein offerings, Scott Boatright doing everything he can. But, in the end, cattle. . .they have the same gestation period as humans. Five thousand, how many, they slaughter a day, there are five thousand cattle.”

3. Prologis, Inc. (NYSE:PLD)

Number of Hedge Fund Holdings: 56

Cramer discussed warehouse real estate firm after speaking with the firm’s CEO on Mad Money. Prologis, Inc. (NYSE:PLD)’s shares have gained 23% year-to-date and the firm has seen several analysts share their thoughts about it in the meantime. For instance, BMO Capital upgraded the shares from Underperform to Market Perform and set a $119 share price target for Prologis, Inc. (NYSE:PLD) in October. The firm pointed out that the real estate company had transformed its data center business to an ownership model. During the same month, Truist raised Prologis, Inc. (NYSE:PLD)’s share price target to $131 from $120 and kept a Buy rating on the shares. The upgrade came after the firm’s third-quarter earnings report. More recently, BofA raised the share price target to $144 from $137 and kept a Buy rating. Ahead of his interview with Prologis, Inc. (NYSE:PLD) CEO Hamid Moghadam, Cramer wondered whether the stock was worth buying. In this appearance, he discussed the CEO’s comments about the data center buildout. With energy proving to be the biggest barrier to big tech’s AI ambition, Cramer revealed that Moghadam believes it might prevent excessive data center construction:

“I had the king of warehouses, on last night. Hamid Moghadam from Prologis. And he’s saying, the gating factor of energy is going to make it so we don’t overbuild.”

2. CoreWeave, Inc. (NASDAQ:CRWV)

Number of Hedge Fund Holdings: 62

Data center infrastructure provider CoreWeave, Inc. (NASDAQ:CRWV)’s shares are ending the year on a strong note, as they are up by 87% since their IPO in March. More recently, though, the shares have struggled as they have lost 46% since late October. The year’s final quarter has seen reports surface about delays in data center buildout and worries about an AI bubble. However, Cramer has continued to remain optimistic about CoreWeave, Inc. (NASDAQ:CRWV) as he believes that the firm enjoys a close relationship with AI chip giant NVIDIA and has a good business model. December has also seen several analysts share their thoughts about the data center infrastructure company. For instance, Citi resumed coverage on CoreWeave, Inc. (NASDAQ:CRWV) but cut the share price target to $135 from $192 while keeping a Buy rating on the shares. Cramer has frequently discussed the data center worries in his morning appearances. The CNBC TV host believes that the sector lacks a sufficient number of qualified workers to build the computing complexes. In this appearance, he dismissed the notion that CoreWeave, Inc. (NASDAQ:CRWV)’s share price dip was merited:

“Look data centers are hard to build [inaudible] Michael Intrator said. . CoreWeave, the stock is down badly, which is silly.”

1. GE Vernova Inc. (NYSE:GEV)

Number of Hedge Fund Holdings: 108

GE Vernova Inc. (NYSE:GEV) is an industrial machinery firm. Its shares have gained 95% year-to-date, with a recent 16% jump coming on December 10th. On that day, the stock rose after the firm boosted its revenue forecast for 2026. GE Vernova Inc. (NYSE:GEV) expects to post 16% to 18% organic revenue growth and 20% electrification revenue growth in 2026. The firm also forecast 2026 revenue to sit between $41 billion and $42 billion, which is significantly higher than the 2025 revenue forecast of $36 billion to $37 billion. After the investor update, Baird raised GE Vernova Inc. (NYSE:GEV)’s share price target to $816 from $706 and kept an Outperform rating on the shares. The upgrade from Baird came after Wells Fargo had increased the share price target to $831 from $717 and kept an Outperform rating. The bank pointed out that it had upgraded its revenue, operating income, and other forecasts for GE Vernova Inc. (NYSE:GEV) after the company’s latest update. Cramer has repeatedly praised the firm in 2025 as he continues to believe it is the only one capable of delivering nuclear power plants. In this appearance, he discussed GE Vernova Inc. (NYSE:GEV)’s natural gas business:

“What you really have to worry about is GE Vernova and whether most of these are going to be built on gas. And natural gas turbines. And I keep pointing this out, over and over again, you can’t get them, you can’t get them.

“Yeah wind’s gone. Fortunately, I think that GEV, they realized that the future of wind was nill.”

While we acknowledge the potential of GEV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GEV and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.